Dana-Farber Inks Research, Supply Deal for MorphoSys' Slonomics Tech

The Department of Cancer Immunology and AIDS at Dana-Farber will use the synthetic biology platform as part of research to develop transient immunity against life-threatening viral infections.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.